chevron_leftBack
As of 13 June 2026, Muller & Phipps (Ceylon) PLC has a market cap of $1.95M USD, ranking #47245 globally and #269 in Sri Lanka.
It ranks #4184 in the Healthcare sector, and #1323 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.95MUSD
650.9M LKR
Enterprise Value
$2.75MUSD
926.18M LKR
Revenue (TTM)
$1.76MUSD
585.16M LKR
EBITDA (TTM)
-$208.6KUSD
-70.38M LKR
Net Income (TTM)
-$319.77KUSD
-106.51M LKR
EBITDA Margin
-12%
Profit Margin
-18%
PS Ratio
1.1
PB Ratio
5.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
69
Founded
1852
Website
mpceylon.lk
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 5% | 9.5% | -8% | -8% | 92% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MULL.N0000
Muller and Phipps (Ceylon) PLC
ISIN: LK0126N00009
Shares Out.:
Shares Outstanding:
283.0M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.10 LKR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Muller & Phipps (Ceylon) PLC
Muller & Phipps (Ceylon) PLC, through its subsidiary, Muller & Phipps (Health Care) Limited, engages in importing, marketing, distributing, and selling of drugs and pharmaceutical products in Sri Lanka. The company was founded in 1852 and is based in Colombo, Sri Lanka. Muller & Phipps (Ceylon) PLC is a subsidiary of E.B. Creasy & Company PLC.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
39M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
28M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
18M%
|
97.4
|
|
SIX: RO
|
$321.52B
16M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
15M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
14M%
218.9B CHF
|
20.5
|
chevron_leftBack